Search by Drug Name or NDC
NDC 66794-0233-42 Dexmedetomidine 200 ug/2mL Details
Dexmedetomidine 200 ug/2mL
Dexmedetomidine is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Piramal Critical Care Inc. The primary component is DEXMEDETOMIDINE HYDROCHLORIDE.
Product Information
| NDC | 66794-0233 |
|---|---|
| Product ID | 66794-233_0d08873b-53a6-29e1-e063-6394a90ac159 |
| Associated GPIs | 60206030102020 |
| GCN Sequence Number | 044671 |
| GCN Sequence Number Description | dexmedetomidine HCl VIAL 200MCG/2ML INTRAVEN |
| HIC3 | H2E |
| HIC3 Description | SEDATIVE-HYPNOTICS,NON-BARBITURATE |
| GCN | 42360 |
| HICL Sequence Number | 020971 |
| HICL Sequence Number Description | DEXMEDETOMIDINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Dexmedetomidine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Dexmedetomidine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 200 |
| Active Ingredient Units | ug/2mL |
| Substance Name | DEXMEDETOMIDINE HYDROCHLORIDE |
| Labeler Name | Piramal Critical Care Inc |
| Pharmaceutical Class | Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA202126 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 66794-0233-42 (66794023342)
| NDC Package Code | 66794-233-42 |
|---|---|
| Billing NDC | 66794023342 |
| Package | 25 VIAL, GLASS in 1 CARTON (66794-233-42) / 2 mL in 1 VIAL, GLASS (66794-233-02) |
| Marketing Start Date | 2021-05-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |